110 related articles for article (PubMed ID: 16860391)
1. Cytotoxicity of 17 tetrahydroisoquinoline derivatives in SH-SY5Y human neuroblastoma cells is related to mitochondrial NADH-ubiquinone oxidoreductase inhibition.
Kotake Y; Sekiya Y; Okuda K; Ohta S
Neurotoxicology; 2007 Jan; 28(1):27-32. PubMed ID: 16860391
[TBL] [Abstract][Full Text] [Related]
2. 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism.
Storch A; Kaftan A; Burkhardt K; Schwarz J
Brain Res; 2000 Feb; 855(1):67-75. PubMed ID: 10650131
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
Biochem Pharmacol; 1995 Nov; 50(11):1903-11. PubMed ID: 8615871
[TBL] [Abstract][Full Text] [Related]
4. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J
J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525
[TBL] [Abstract][Full Text] [Related]
5. [Tetrahydroisoquinoline derivatives as possible Parkinson's disease-inducing substances].
Kotake Y
Yakugaku Zasshi; 2002 Nov; 122(11):975-82. PubMed ID: 12440154
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective function of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, [R-(-)-BPAP], against apoptosis induced by N-methyl(R)salsolinol, an endogenous dopaminergic neurotoxin, in human dopaminergic neuroblastoma SH-SY5Y cells.
Maruyama W; Yi H; Takahashi T; Shimazu S; Ohde H; Yoneda F; Iwasa K; Naoi M
Life Sci; 2004 May; 75(1):107-17. PubMed ID: 15102525
[TBL] [Abstract][Full Text] [Related]
7. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, a Parkinsonism-inducing endogenous toxin, increases alpha-synuclein expression and causes nuclear damage in human dopaminergic cells.
Shavali S; Carlson EC; Swinscoe JC; Ebadi M
J Neurosci Res; 2004 May; 76(4):563-71. PubMed ID: 15114628
[TBL] [Abstract][Full Text] [Related]
8. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-like compounds on mitochondrial respiration.
Suzuki K; Mizuno Y; Yoshida M
Adv Neurol; 1990; 53():215-8. PubMed ID: 2122645
[TBL] [Abstract][Full Text] [Related]
9. Parkinsonism-preventing activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline derivatives in C57BL mouse in vivo.
Okuda K; Kotake Y; Ohta S
Biol Pharm Bull; 2006 Jul; 29(7):1401-3. PubMed ID: 16819177
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and neurotoxicity of tetrahydroisoquinoline derivatives for studying Parkinson's disease.
Abe K; Saitoh T; Horiguchi Y; Utsunomiya I; Taguchi K
Biol Pharm Bull; 2005 Aug; 28(8):1355-62. PubMed ID: 16079473
[TBL] [Abstract][Full Text] [Related]
11. Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system.
Takahashi T; Deng Y; Maruyama W; Dostert P; Kawai M; Naoi M
J Neural Transm Gen Sect; 1994; 98(2):107-18. PubMed ID: 7734108
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain.
Suzuki K; Mizuno Y; Yamauchi Y; Nagatsu T; Mitsuo Y
J Neurol Sci; 1992 Jun; 109(2):219-23. PubMed ID: 1353109
[TBL] [Abstract][Full Text] [Related]
13. Methylglyoxal increases dopamine level and leads to oxidative stress in SH-SY5Y cells.
Xie B; Lin F; Peng L; Ullah K; Wu H; Qing H; Deng Y
Acta Biochim Biophys Sin (Shanghai); 2014 Nov; 46(11):950-6. PubMed ID: 25274329
[TBL] [Abstract][Full Text] [Related]
14. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.
Xie HR; Hu LS; Li GY
Chin Med J (Engl); 2010 Apr; 123(8):1086-92. PubMed ID: 20497720
[TBL] [Abstract][Full Text] [Related]
15. A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease.
Xie B; Lin F; Ullah K; Peng L; Ding W; Dai R; Qing H; Deng Y
Biochem Biophys Res Commun; 2015 Apr; 459(3):361-6. PubMed ID: 25744031
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's disease cybrids, differentiated or undifferentiated, maintain morphological and biochemical phenotypes different from those of control cybrids.
Appukuttan TA; Ali N; Varghese M; Singh A; Tripathy D; Padmakumar M; Gangopadhyay PK; Mohanakumar KP
J Neurosci Res; 2013 Jul; 91(7):963-70. PubMed ID: 23653325
[TBL] [Abstract][Full Text] [Related]
17. Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders.
Ben-Shachar D; Zuk R; Gazawi H; Ljubuncic P
Biochem Pharmacol; 2004 May; 67(10):1965-74. PubMed ID: 15130772
[TBL] [Abstract][Full Text] [Related]
18. D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease.
Imamura K; Takeshima T; Kashiwaya Y; Nakaso K; Nakashima K
J Neurosci Res; 2006 Nov; 84(6):1376-84. PubMed ID: 16917840
[TBL] [Abstract][Full Text] [Related]
19. Generation of reactive oxygen species accounts for cytotoxicity of an endogenous dopaminergic neurotoxin, (R)-N-methylsalsolinol, to differentiated dopaminergic SH-SY5Y cells.
Minami C; Deng Y; Maruyama W; Takahashi T; Kawai M; Nakahara D; Naoi M
J Neural Transm (Vienna); 1998; 105(4-5):397-405. PubMed ID: 9720969
[TBL] [Abstract][Full Text] [Related]
20. Detection of a novel neurotoxic metabolite of Parkinson's disease-related neurotoxin, 1-benzyl-1,2,3,4- tetrahydroisoquinoline.
Kotake Y; Sekiya Y; Okuda K; Ohta S
J Toxicol Sci; 2014; 39(5):749-54. PubMed ID: 25242405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
